Inge-Britt Y Linden

This inventor holds 13 USPTO granted patents. Top assignees: Orion-Yhtyma Oy, Orion Corporation. Active years: 1990-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inge-Britt Y Linden. Retrieved from https://idiyas.com/inventor/inge-britt-y-linden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 7.9

ph-index = 5

Forward Citations = 217(Granted Patents)

Location History:

Helsinki, FI (1990 - 2000)
Espoo, FI (2001)

Company Filing History:

Years Active: 1990-2001

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6201027 - Substituted &bgr; diketones and their use (2001-03-13),

2. 6121303 - Pharmacologically active catechol derivatives (2000-09-19),

3. 5889037 - Pharmacologically active catechol derivatives (1999-03-30),

4. 5614541 - Pharmacologically active catechol derivatives (1997-03-25),

5. 5446194 - Pharmacologically active catechol derivatives (1995-08-29),

6. 5362733 - Pharmacologically active catechol derivatives (1994-11-08),

7. 5292771 - Substituted .beta.-diketones and their use (1994-03-08),

8. 5288750 - Substituted .beta.-diketones (1994-02-22),

9. 5283352 - Pharmacologically active compounds, methods for the preparation thereof (1994-02-01),

10. 5185370 - Substituted .beta.-diketones and their use (1993-02-09),

11. 5112861 - Method of treating Parkinson's Disease using pentanedione derivatives (1992-05-12),

12. 5001152 - Use of catechol-O-methyl transferase (COMT) inhibitors and their (1991-03-19),

13. 4963590 - Pharmacologically active compounds, methods for the preparation thereof (1990-10-16),

Title: The Innovative Mind of Inge-Britt Y. Linden

Introduction

Inge-Britt Y. Linden, an accomplished inventor based in Helsinki, Finland, has made significant contributions to the field of pharmacology through her inventive prowess. With a remarkable portfolio of 13 patents, she has become a notable figure in the realm of chemical innovations.

Latest Patents

Her latest patents showcase her expertise and creativity in developing novel chemical compounds. Among these, the patent entitled "Substituted β diketones and their use" focuses on compounds represented by a specific formula, highlighting their potential applications in various pharmaceutical formulations. Additionally, her work on "Pharmacologically active catechol derivatives" presents a compound with unique substituents, aiming to enhance therapeutic efficacy. These innovative compounds include pharmacologically active components that can significantly advance medical research and drug development.

Career Highlights

Inge-Britt has had a noteworthy career, particularly with her collaboration at Orion-yhtyma Oy and Orion Corporation. These esteemed organizations have provided her with a platform to harness her talents, contributing to multiple projects that push the boundaries of chemical research and pharmaceutical applications.

Collaborations

Throughout her professional journey, Inge-Britt has had the privilege of working alongside respected colleagues such as Pentti Pohto and Erkki J. Honkanen. These collaborations have fostered an environment of shared knowledge and innovation, leading to groundbreaking discoveries in her field.

Conclusion

Inge-Britt Y. Linden exemplifies the spirit of innovation and dedication in the world of pharmaceuticals. Her extensive patent portfolio and meaningful collaborations reflect her commitment to advancing science for therapeutic purposes. As she continues to explore new frontiers, Inge-Britt's work remains a vital contribution to the field of pharmacology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]